These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14889478)

  • 21. [Current general principles of the treatment of Hodgkin's disease, lymphosarcoma and reticulosarcoma].
    Bernard J
    Rev Prat; 1966 Mar; 16(7):871-9. PubMed ID: 5324749
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of radioactive phosphorus (P32) on normal tissues; a histologic study of the changes induced in the organs of patients with malignant lymphomas.
    PLATT WR
    Arch Pathol (Chic); 1947 Jan; 43(1):1-14. PubMed ID: 20284507
    [No Abstract]   [Full Text] [Related]  

  • 23. The treatment of malignant lymphoma; Hodgkin's disease and lymphosarcoma.
    HYNES JF
    Miss Valley Med J; 1956 Nov; 78(6):273-4. PubMed ID: 13369388
    [No Abstract]   [Full Text] [Related]  

  • 24. The treatment of Hodgkin's disease.
    INNES J
    Practitioner; 1951 Nov; 167(1001):555-7. PubMed ID: 14883063
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of hemoblastosis with triethylene melamine].
    LINKE A; LASCH HG
    Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of TEM on chronic leukemia, lymphogranulomatosis and lymphosarcoma].
    HAEHNER E; HEINEN W; LOOSEN H; SCHMIDT H
    Med Klin; 1954 May; 49(21):853-4; passim. PubMed ID: 13164965
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid].
    BERNARD J; MATHE G; WEIL M
    Sang; 1957; 28(1):80-2. PubMed ID: 13432604
    [No Abstract]   [Full Text] [Related]  

  • 28. [Naphthylaminic therapy of some hemolymph diseases].
    DE BLASIIS M
    Minerva Med; 1952 Oct; 43(82):641-9. PubMed ID: 13024936
    [No Abstract]   [Full Text] [Related]  

  • 29. [Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
    KLIMA R; HORNISCHER R
    Wien Med Wochenschr; 1953 Jan; 103(1):11-4. PubMed ID: 13049846
    [No Abstract]   [Full Text] [Related]  

  • 30. Salient factors in the treatment of Hodgkin's disease and lymphosarcoma with roentgen rays.
    DESJARDINS AU
    Am J Roentgenol Radium Ther; 1945 Dec; 54():707-22. PubMed ID: 21011624
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimentation with actinomycin].
    HUGUENIN R; TRUHAUT R; BOURDIN JS
    Presse Med (1893); 1954 May; 62(35):740. PubMed ID: 13177453
    [No Abstract]   [Full Text] [Related]  

  • 32. THE USE OF RADIOACTIVE ISOTOPES IN THE TREATMENT OF LYMPHOMAS.
    ARIEL IM
    Am J Roentgenol Radium Ther Nucl Med; 1963 Aug; 90():311-24. PubMed ID: 14048124
    [No Abstract]   [Full Text] [Related]  

  • 33. [Radiophosphorus and fungoid mycosis].
    GATE J; BERGER M; PELLERAT J; VAYRE J
    Lyon Med; 1953 Feb; 188(7):147-8. PubMed ID: 13062715
    [No Abstract]   [Full Text] [Related]  

  • 34. Survival in advanced Hodgkin's disease and non-Hodgkin's lymphoma.
    Rubin AD; Tadros G; Hanley D; Rubin GH; Todd D
    N J Med; 1996 Oct; 93(10):33-8. PubMed ID: 8918134
    [No Abstract]   [Full Text] [Related]  

  • 35. [Phosphorus 32 in several cases of Hodgkin's disease].
    HUGUENIN R; SARACINO R; GUELFI J
    Bull Assoc Fr Etud Cancer; 1951; 38(4):414-22. PubMed ID: 14916260
    [No Abstract]   [Full Text] [Related]  

  • 36. Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma.
    Leavitt RD; Ratanatharathorn V; Ozer H; Ultmann JE; Portlock C; Myers JW; Kisner D; Norred S; Spiegel RJ; Bonnem EM
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):18-23. PubMed ID: 3589702
    [No Abstract]   [Full Text] [Related]  

  • 37. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S88-95. PubMed ID: 12739340
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnostics, classification and high dose chemotherapy in non Hodgkin's and Hodgkin's lymphoma].
    Nowak WS; Jurczak W; Wójcik M; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():73-9. PubMed ID: 10494187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reporting outcomes in Hodgkin's disease and lymphoma.
    Dixon DO; McLaughlin P; Hagemeister FB; Freireich EJ; Fuller LM; Cabanillas FF; Gehan EA
    J Clin Oncol; 1987 Oct; 5(10):1670-2. PubMed ID: 3655864
    [No Abstract]   [Full Text] [Related]  

  • 40. [Apropos of a case of lymphosarcoma treated with prednisolone and roentgenotherapy].
    PICASSO VM
    Nicar Med; 1959; 15():112-4. PubMed ID: 14432695
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.